Kelkheim, Germany

Andreas Busch



Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Andreas Busch: Innovator in Medical Research

Introduction

Andreas Busch is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of medical research, particularly in the area of treatments for aging processes and potassium channel proteins. With a total of 4 patents, his work has the potential to impact various therapeutic approaches.

Latest Patents

One of his latest patents is a method for identifying compounds that treat aging processes in the coronary circulatory system. This invention focuses on modifying the activity of the urotensin II receptor, influencing genes or gene products involved in the structure, formation, or breakdown of the extracellular matrix. Another significant patent involves a nucleic acid molecule encoding the potassium channel protein KCNQ5. This patent describes DNA encoding KCNQ5 or a polypeptide with KCNQ5 activity, along with related vectors, host cells, and methods for screening compounds that modify the activity of the potassium channel KCNQ5.

Career Highlights

Throughout his career, Andreas Busch has worked with various companies, including Tinnitus Forschungs- und Entwicklungs GmbH and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical research.

Collaborations

Andreas has collaborated with notable professionals in his field, including Hans Peter Zenner and J. Peter Ruppersberg. These collaborations have further enriched his research and contributed to his success as an inventor.

Conclusion

Andreas Busch is a distinguished inventor whose work in medical research has led to valuable patents and collaborations. His innovative approaches to treating aging processes and potassium channel proteins highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…